during regular dialysis sessions on a cellulose triacetate membrane (CT 110 G; 1.10 m2; Baxter), with four
The concept of biocompatibility in haemodialysis has different random heparin protocols: one high-UFH gradually expanded in recent years [1] , and usually regimen (HHR) at 90 IU/kg body-weight (b.w.) and refers to the entire extracorporeal circuit, the dialysis one low-UFH regimen (LHR) at 50 IU/kg b.w., and bath, and the sterilizing agents. Unfractionated heparin with a LMWH (nadroparin calcium) at 85 (HHR) or ( UFH ), used at an annual dose of 800 000 to 1 500 000 45 (LHR) IU/kg b.w. Blood granulocytes, platelet IU and for 10-20 years, has been only recently recogcounts, and plasma granulocyte degranulation prodnized as a potential factor affecting biocompatibility ucts (elastase, lactoferrin) were measured serially [2, 3] , and its biological effects have been rarely considduring 4 h dialysis sessions.
ered in vitro [4, 5] , ex vivo [6 ] , or in vivo [7] [8] [9] [10] .
Results. After 10 min, the reduction in PMNs with
Various polymorphonuclear neutrophil (PMN ) end-UFH was 29.5% for HHR (P<0.01) and 28.5% for functions can be modulated by heparins. At concentra-LHR (P<0.01), and only 16.8 and 18.6% with LMWH tions (anti-Xa activities) higher than those used in (NS ), significantly higher for HHR with UFH than haemodialysis, a more PMN-inhibiting effect of UFH with LMWH (P<0.01). At 60 min, the elastase over a low-molecular-weight heparin (LMWH ) has increase with HHR was greater, 61% with UFH been reported in vitro. This action is considered to be (P<0.01) and 37.8% with LMWH (P<0.01), significa dose-dependent effect [11] [12] [13] [14] [15] [16] and linked to the size, antly higher than LHR for UFH (P<0.05) or LMWH charge, and degree of sulphation [11, 13, 16 ] which (P<0.05). The overall decrease in platelets (with favours LMWH. Conversely, at lower concentrations, LMWH P<0.01) and the overall increase in lactoferrin such as those used in haemodialysis, the PMN-stimu-(P<0.001) were not different between heparinization lating action of heparins has been poorly investigated procedures.
as 
Blood samples

Subjects and methods
The samples were taken from the arterial needle, before the Design extracorporeal circuit was started and before injection of the anticoagulant (0 min), then from the outlet side, i.e. from Each patient underwent four studies, two haemodialysis the venous side. Blood was drawn on sodium citrate for sessions with an UFH and two sessions with a LMWH. For heparin, on tripotassium EDTA for PMN degranulation each type of heparin, one session was conducted using a markers and cell counts, and on lithium heparin for total high-heparin regimen (HHR), and the other using a low-proteins. The samples were chilled on ice and sent for analysis heparin regimen (LHR). The order of inclusion was allocated within 1 h. according to a computerized randomization model and a 2-week period separated each study. With the exception of
Plasma analyses
the heparinization procedures used, the other technical dialysis conditions were identical for each patient, and used for Plasma heparin level was studied at 0, 10, 60, 120 and at least 1 month prior to the study. The University and 240 min. The measurement of heparin activity was conducted Hospitals Ethics Review Committee gave its approval to the as anti-Xa (aXa) inactivation using chromogenic substrate procedures.
(S. 2337) and bovine factor X (Chromogenix, Milano, Italy) [22] . Different calibrations were used for UFH ( UFH IU )
Patients
and LMWH (LMWH IU ). The measurements were all performed using a Corning spectrophotometer. Ten patients were included after giving informed consent: six Elastase and lactoferrin were measured in duplicate at 0, men, four women, mean age 57.8 years (range 33 to 72), 10, 60, 120 and 240 min as markers of PMN degranulation. mean duration treatment on haemodialysis 7.9 years (range The measurement methods have been reported in detail 2.5-14) and for at least 1 year with a high-permeability elsewhere [15, 23] . Briefly, elastase in a complex with a 1 -dialysis membrane: polyacrylonitrile (AN69) (Hospal, proteinase inhibitor, and lactoferrin were measured by highly Meyzieu, France) (four patients), polysulphone (Fresenius, sensitive enzyme-linked immunoassay, using a kit obtained Bad Homburg, Germany) (two patients), polymethylmetha-from Merck (Darmstadt, Germany) for elastase and using crylate ( Toray, Tokyo, Japan) (two patients), and cellulose antihuman lactoferrin rabbit IgG (Dako, Glostrup, triacetate (Baxter, IL, USA) (two patients). The causes of Denmark) for lactoferrin. Sensitivity and reproducibility were renal failure were primary glomerulonephritis (4), interstitial 100 ng/ml and 97.9% for elastase, and 5 ng/ml and 96% for nephritis or uropathy (3), renal vascular disease (2), and lactoferrin respectively. polycystic kidney disease (1). All patients were anuric, in a Total proteins were measured using the biuret method stable clinical condition, and none of them had any other (Hitashi 737). The haemoconcentration in the course of the disease or was taking any medication known to affect leuko-dialysis session was estimated by using the quotient of protein cyte function.
concentration of the sample and of baseline protein concentration to correct the plasma values and cell counts.
Dialysis and heparinization protocol Blood cell counts
The dialysis sessions were conducted over 4 h with a bicarbonate bath prepared with ultrapurified water (<2 colony-PMNs and platelets were measured in duplicate at 0, 10, 60, forming units (c.f.u.)/100 ml, endotoxins <0.06 EU/ml ). The 120 and 240 min using an automatic counter, ABX Minos. calcium concentration in the bath was 1.50 mmol/l. The ultrafiltration required by the patient was constant throughout the session. The high-permeability capillary-type dialysis Statistics membrane was made of cellulose triacetate (CT 110 G; 1.10 m2; Baxter, IL, USA), and blood lines were polyvinyl-The data corrected for haemoconcentration were obtained from repeated measures design with three within-subjects chloride. The entire extracorporeal circuit was sterilized by factors: two factors at two levels, heparin type and heparin stable, being below 0.46 IU/ml with UFH, whereas regimen, and a time factor at five levels not equally spaced. with LMWH the aXa activity reached 1.25 IU/ml at Therefore multivariate analysis of variance (MANOVA) with 10 min and then steadily decreased to 0.56 IU/ml at a difference contrast and repeated measurement design, was the end of the session. For LHR, aXa activity reached used to characterize the patterns of change of dependent 0.22 IU/ml at the end of the session with UFH, whereas variables over time factor [24] . This method allows the with LMWH it rose to 0.72 IU/ml at 10 min and then analysis, in a global way, of the overall variation of dependent decreased to 0.29 IU/ml at the end of the session. For variables during the dialysis session. If necessary, a reference LHR, mean heparin concentrations were significantly time-point was also chosen, at 10 min for PMN counts and lower as compared with HHR, with UFH (P<0.001) at 60 min for plasma elastase. With each heparinization condition, a heparin regimen effect was studied by comparing as well as LMWH (P<0.05).
LHR and HHR for the same type of heparin, and a heparin type effect was studied by comparing LMWH and UFH for Blood cell counts the same regimen. The statistical significance of linear correlations was interpreted by the Fisher's transformation test.
The variation of cell counts in the course of the session The homogeneity of values for each variable was verified was studied from baseline (0 min). There was no at the start of the session (0 min) in the four conditions. If difference between values at baseline. All calculations were conducted using the SPSS program UFH, the PMNs decrease was significant, reaching MANOVA (release 6.1 of SPSS Windows, IL, USA). The 29.5% for HHR (P<0.01) and 28.6% for LHR level of significance was chosen at 0.05. But due to the small (P<0.01). With LMWH, this decrease was 16.8 and number of subjects studied (n=10), we considered that a 18.6% respectively (NS). An effect of heparin type level of 0.10 could also be indicated to bring down type II only existed statistically at 10 min for HHR, with a error and to suggest a significant trend [25] .
greater decrease with UFH than with LMWH (P<0.01).
The steadily decrease in platelets exceeded 10% at
Results
min (results not shown)
. The overall variation in platelet counts was significant for LMWH (P<0.01) Ultrafiltration and haemoconcentration and only with a tendency for UFH (P=0.08). No regimen or heparin type effect was observed. The mean ultrafiltration during the session was None of the overall cell variations during the dialysis 3001±207 ml (range 2778±227 to 3167±195 ml for session, and PMN decrease at 10 min, was related to the four conditions studied ) (mean±SEM ). The mean the heparin activity at 10 min (aXa, UFH IU or haemoconcentration at the end of the session reached LMWH IU ). In addition, the PMN counts at other 28.9±6.0% (range 25.9±4.8 to 30.1±6.1% for the time-points of the session were not related to the four studies). There were no statistical significant heparin activity. difference between the four situations tested.
Degree of heparinization (Figure 1) Plasma markers of PMN degranulation
Variation of variables during the session were analysed The overall variation of heparin activity during the session was studied from 10 min by aXa activity. For from baseline (0 min).
The four baseline levels of plasma elastase were not HHR, the mean value of the heparin activity was statistically different. In an in vitro assay we found Unfractionated heparin ( UFH ) and low-molecularthat elastase level was not affected by UFH or by weight heparin (LMWH, nadroparin calcium) were LMWH in a range of aXa activity up to 1 IU/ml, and tested at dosages corresponding to those usually was reduced by less than 10% up to 2.1 IU/ml, without administered in chronic haemodialysis (high-heparin difference between the heparin types (data not shown). regimen, HHR) and at doses adapted to minimum The overall variation in elastase ( Figure 3 ) was signi-administration in the context of bleeding risk ( lowficant during the four studies. From baseline to 60 min, heparin regimen, LHR) [26] [27] [28] . We found that aXa a significant increase in elastase was observed with ( UFH IU and LMWH IU ) for each type of heparin HHR, reaching 61% with UFH (P<0.01) and 37.8% was comparable to those recommended ( Figure 1 ) with LMWH (P<0.01). Until 60 min, there was no [26, 27] . The extracorporeal circuit characteristics used significant heparin type effect, but a regimen effect was are considered to meet acceptable biocompatibility significant with UFH (P<0.05) as well as with LMWH standards [1] [2] [3] , including the use of a cellulose tri-(P<0.05). Variations up to this time point were not acetate high-permeability dialysis membrane. This correlated with the heparin activity at 10 min.
membrane is deemed to be as biocompatible as During UFH, the mean lactoferrin value at baseline synthetic high-permeability membranes [29, 30] . Blood was higher for HHR than for LHR (P<0.05). samples were collected from the outlet side, i.e. on the Therefore analysis was conducted with relative values venous side, instead of the inlet side, because it appears compared to the baseline values. The overall increase to be more relevant when addressing functional in lactoferrin mostly reached a plateau profile and was changes of the PMNs [31] [32] [33] . significant for all procedures (P<0.001) ( Figure 4) .
We show that the action of heparin on early granuloNo heparin type or regimen effect was observed. cytopenia (at 10 min) depends on the nature of heparin and on heparin regimen ( Figure 2 may explain the more pronounced effect of UFH on factor of altered proteolysis by leukocyte stimulation [19, 34, 35] . the PMN count as compared to LMWH. In addition, in vitro, this stimulating action depends on heparin
The precise mechanism of heparin action on PMNs is not known. Our study allows the exclusion of an concentration (aXa) [12, 14, 17] . We observed a particular granulocytopenic effect of the high regimen with insufficient anticoagulation and subsequent clot formation mechanism, that can induce leukopenia but that UFH as compared to LMWH. These findings were not observed by Otte et al. for total leukocyte counts, cannot induce neutrophil degranulation, during in vitro haemodialysis [5] . Indeed, we observed the most stimusince these authors only studied various administrations of the same dose of UFH [7] . In the present latory effect during the high-heparin regimen ( Figures  2 and 3 ), and as a result a direct activating effect of study, we can rule out a potential pharmacokinetic difference of heparin action on PMNs, since both heparins should be considered. At a concentration less than 2 IU/ml (aXa) observed during routine dialysis, heparins were used intravenously and granulocytopenia was observed in the early session.
UFH in vitro provokes an up-regulation of endothelial adhesion leukocyte receptors (beta 2-integrin) [12] . The PMN degranulation with increased plasma elastase was shown to be linked to the high-heparin This receptor up-regulation is also induced by the dialysis membranes known to produce an in vivo regimen, whatever the nature of heparin ( Figure 3) . However, this study failed to demonstrate a significant leukopenia [38] . In addition, heparin can provoke a granulocyte degranulation in a calcium-dependent correlation between elastase increase and heparin activity level (aXa). The more potent effect of the high-manner [15] . This heparin action on PMNs is thought to be due to a specific polysaccharide sequence, differheparin dose over the low dose is concordant with the studies on PMN degranulation in vitro [14,15,17] and ent from that of antithrombin III [16, 39] . We propose that heparin could act in vivo on blood PMNs in with recent reports showing a reduced PMN degranulation during dialysis with citrate as compared with synergy with the stimulatory effect of the dialysis membrane, by acting on membrane pre-activated cells. UFH [9, 10] . A potential advantage of LMWH over UFH known in vitro with superoxide ion production This membrane starter effect may be compared to that of i.v. infusion of phorbol myristate acetate, which [15] , cannot be confirmed in the present study in vivo. In addition, the effect on protein catabolism of this facilitates the UFH-induced leukopenia in rabbits [17] .
The PMN and elastase variation might also be increase of elastase [34, 35] may be more important with UFH than with LMWH. Indeed, UFH is known affected by heparin upper levels and industrial production. The heparin concentration threshold (aXa) to be more strongly bound with elastase than LMWH, thus reducing the action of alpha-proteinase inhibitor between the stimulatory action at low concentrations and the inhibitory effect at higher concentrations has [36 ] . We have measured that, at doses used usually in haemodialysis, both heparin types did not influence rarely been studied. This threshold is estimated to be in vitro 1-2 IU/ml [11, 12, 15] , mostly greater than significantly the measurement of plasma elastase in complex with a 1 -proteinase inhibitor. Recently, how-regular heparin concentrations used in dialysis, and therefore in favour of the heparin stimulatory action ever, it was shown in vitro that UFH, and LMWH to a lesser degree, directly inhibits the activity of elastase during the dialysis session in the present study. Since we used the same batch for each type of heparin, a [37] . Unfortunately, the final effect of heparins on elastase is unknown in vivo because it is impossible to variable effect according to the batch of heparin [13, 14] can also be ruled out. measure the specific biological activity of elastase, which is mixed with other serine proteinase activities.
The decrease in PMN count ( Figure 2 ) and elastase concentration ( Figure 3 ) that was observed in the Finally, heparins could also act on amyloidogenesis, per se as a source of glycosaminoglycans, or as a second part of the dialysis session has also been heparin in neutrophil activation during simulated extracorporeal reported by other authors. Firstly, a comparable PMN In the present study, the heparin type and dose effects 16 
